4 November 2026 - Sectra (STO: SECT B), a medical imaging IT and cybersecurity company, announced on Wednesday that it has signed a seven-year agreement with Mount Sinai Health System in New York to deploy Sectra Reporting, integrating medical imagin...
4 November 2026 - Biotechnology company Pentixapharm Holding AG (Frankfurt Prime Standard: PTP) on Wednesday reported further progress towards its pivotal Phase 3 PANDA study, with US ethics approval secured and no concerns raised by the US Food and ...
4 November 2026 - ABIONYX Pharma (Euronext Paris:ABNX), a biopharma company focused on breakthrough biotherapies to address life-threatening conditions with no effective treatments, announced on Wednesday that it has signed a strategic partnership wi...
4 November 2026 - Regenerative medicine company StimLabs announced on Tuesday the commercial launch of DermaForm, an FDA 510(k)-cleared porcine-derived particulate collagen scaffold that manages a range of acute and chronic wounds.DermaForm was devel...
4 November 2026 - Samsung Biologics (KRX:207940), a South Korea-based contract development and manufacturing organisation (CDMO), announced on Tuesday that it has achieved a 'Negligible Risk' rating in the latest Morningstar Sustainalytics ...